Your browser doesn't support javascript.
loading
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Philis-Tsimikas, Athena; Aroda, Vanita R; De Block, Christophe; Billings, Liana K; Liebl, Andreas; Sivarathinasami, Ramsathish; D'Cruz, John M; Lingvay, Ildiko.
Affiliation
  • Philis-Tsimikas A; Scripps Whittier Diabetes Institute, San Diego, CA, USA.
  • Aroda VR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • De Block C; Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Billings LK; NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine, Skokie, IL, USA.
  • Liebl A; Center for Diabetes and Metabolism, m&i-Fachklinik, Bad Heilbrunn, Bad Heilbrunn, Germany.
  • Sivarathinasami R; Novo Nordisk Service Centre India Private Ltd, Bangalore, India.
  • D'Cruz JM; Novo Nordisk Service Centre India Private Ltd, Bangalore, India.
  • Lingvay I; The University of Texas Southwestern Medical Center, Dallas, TX, USA.
J Diabetes Sci Technol ; : 19322968221149041, 2023 Jan 29.
Article in En | MEDLINE | ID: mdl-36710452
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: J Diabetes Sci Technol Journal subject: ENDOCRINOLOGIA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: J Diabetes Sci Technol Journal subject: ENDOCRINOLOGIA Year: 2023 Type: Article Affiliation country: United States